NeuroSense Therapeutics Ltd. ("NeuroSense"), a clinical-stage biotechnology company developing novel treatments for severe neurodegenerative diseases, today reports its financial results for the year ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback